Molecular Imaging

1: Imaging of structure and function with PET/CT
2: PET/MRI
3: SPECT and SPECT/CT
4: Principles of micro x-ray computed tomography
5: Small Animal SPECT, SPECT/CT, and SPECT/MRI
6: Instrumentation and methods to combine small animal PET with other imaging modalities
7: Functional Imaging using Bioluminescent Imaging
8: Optical Multimodality
9: Fiber Optic Fluorescence Imaging
10: Fluorescence Tomography
11: Endomicroscopy
12: Intravital Microscopy
13: Diffuse Optical Tomography
14: Ultrasound
15: Molecular Photoacoustic Tomography
16: Optical Projection Tomography
17: Signal Post Processing/Image Reconstruction

Part II: Chemistry of Molecular Imaging

18: Chemistry of Molecular Imaging: an overview
19: Radiochemistry of PET
20: Radiochemistry of SPECT
21: Nanochemistry for Molecular Imaging
22: Newer Bioconjugation Methods
23: Targeted Antibodies and Peptides
24: Hyperpolarized 13C magnetic resonance imaging – Principles and applications
25: MR Imaging Agents
26: Optical Imaging Agents
27: Ultrasound Contrast Agents
28: Multimodality Agents
29: “Click Chemistry”: Applications to Molecular Imaging
30: The “One-Bead-One-Compound” Combinatorial Approach toIdentifying Molecular Imaging Probes
31: Chemical Biology Approaches to Molecular Imaging
32: Theranostics: Agents for diagnosis and therapy
33: Magnetic Nanoparticles
34: Fluorocarbon Agents For Quantitative Multimodal Molecular Imaging and Targeted Therapeutics
35: Aptamers for Molecular Imaging
36: Toxicology

Part III: Molecular Imaging in Cell & Molecular Biology

37: Overview of Molecular and Cell Biology
38: Systems Biology
39: Protein Engineering
40: Phage Display for Agent Development
41: Molecular Imaging of Gene Therapy
42: Developing diagnostic and therapeutic viral vectors
43: Cell Voyeurism using Magnetic Resonance Imaging
44: Tumor vasculature
45: Hypoxia Imaging
46: Protein-Protein Interaction
47: Fluorescence Reporters/Activatable Cell Penetrating Peptides
48: Imaging of Signaling Pathways

Part IV: Applications of Molecular Imaging

49: Molecular and Functional Imaging of the Tumor Microenvironment
50: Novel MR and PET Imaging in the RT Planning and Assessment of Response of Malignant Gliomas
51: PET Diagnosis and Response Monitoring in Oncology
52: MRS Treatment Response and Detection
53: MRI Treatment Response Assessment – Diffusion
54: Myocardial Metabolism
55: Congestive Heart Failure
56: Molecular Imaging of Atherosclerosis
57: Thrombosis and Embolism
58: Molecular Imaging of Stem Cells in Myocardial Infarction
59: Central Nervous System Molecular Imaging
60: Neuroreceptor Imaging
61: Neurodegeneration
62: Molecular Imaging of Autoimmune Diseases
63: Rheumatoid Arthritis
64: Autoimmune Diabetes
65: Imaging in Asthma

Part V: Molecular Imaging in Drug Evaluation

66: Molecular and Functional Imaging in Drug Development
67: PET Imaging Clinical Trials
68: MR Imaging in Clinical Trials
69: Imaging of Gene Therapy: Basis and Clinical Trials

Part VI: Other

70: Visualization
71: Quantification of Radiotracer Uptake into Tissue
72: Mining High Throughput Data for Candidate Biomarkers as Imaging and Therapeutic Targets
73: Pharmacokinetic Modeling
74: Cost-Effectiveness Analysis/Economics of Probe Development
75: Regulatory and Reimbursement Process for Imaging Agents and Devices